Wageningen University and Research Centre, Plant Research International, Droevendaalsesteeg 1, 6708 PB Wageningen, The Netherlands.
Curr Pharm Des. 2013;19(31):5503-12. doi: 10.2174/1381612811319310006.
Plants are gaining increasingly acceptance as a production platform for recombinant proteins. One reason for this is their ability to carry out posttranslational protein modifications in a similar if not identical way as mammalian cells. The capability of plants to carry out human-like complex glycosylation is well known. Moreover, the targeted manipulation of the plant N-glycosylation pathway allows the production of proteins carrying largely homogeneous, human-type oligosaccharides. These outstanding results have placed plants in a favourable position compared to other eukaryotic expression systems. This review provides a comprehensive summary of the N-glycosylation of plant-produced recombinant proteins, the possible impact of plant-specific N-glycans on the human immune system, and recent advances in engineering the plant N-glycosylation pathway towards the synthesis of (complex) human-type glycan structures, highlighting challenges and achievements in the application of these powerful technologies.
植物作为重组蛋白的生产平台越来越受到认可。原因之一是它们能够以类似于哺乳动物细胞的方式进行翻译后蛋白修饰,如果不是完全相同的话。植物具有进行类似人类的复杂糖基化的能力是众所周知的。此外,对植物 N-糖基化途径的靶向操作允许生产携带主要同质的、人类类型的寡糖的蛋白质。这些出色的结果使植物与其他真核表达系统相比处于有利地位。本文综述了植物生产的重组蛋白的 N-糖基化、植物特异性 N-聚糖对人类免疫系统的可能影响,以及工程植物 N-糖基化途径合成(复杂)人类类型糖基结构的最新进展,强调了这些强大技术应用中的挑战和成就。